Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports Second Quarter Fiscal Year 2013 Results

SALT LAKE CITY, Feb. 5, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its second fiscal quarter ended December 31, 2012. Revenue for the second fiscal...
January 15, 2013 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013

SALT LAKE CITY, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will issue financial results for the second fiscal quarter 2013 following the close of...
December 17, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference

SALT LAKE CITY, Dec. 17, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 2013 J.P. Morgan Annual...
December 10, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Announces Diabetes Collaboration With Sanofi

SALT LAKE CITY, Dec. 10, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq:MYGN) announced today that Myriad RBM, a wholly owned subsidiary of Myriad Genetics, has entered into a research collaboration...
December 07, 2012 18:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer

SALT LAKE CITY, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled "Homologous recombination deficiency (HRD) score predicts pathologic...
November 30, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Supreme Court of the United States to Hear Isolated DNA Patent Case

SALT LAKE CITY, Nov. 30, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) reported today that the Supreme Court of the United States granted certiorari agreeing to hear the case of The...
November 28, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics' Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy

SALT LAKE CITY, Nov. 28, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that a presentation entitled "CCP Score Significantly Predicts PSA Failure After EBRT," was...
November 15, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the Piper Jaffray Healthcare Conference

SALT LAKE CITY, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the Piper Jaffray Healthcare...
November 05, 2012 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Reports First Quarter Fiscal Year 2013 Results

SALT LAKE CITY, Nov. 5, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced results for its first fiscal quarter ended September 30, 2012. Revenue for the first fiscal quarter...
November 01, 2012 16:10 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at the 2012 Credit Suisse Annual Healthcare Conference

SALT LAKE CITY, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the 2012 Credit Suisse Annual...